Induce-1: Report On Safety Run-In Cohorts Combining Inducible T-Cell Co-Stimulatory Receptor (Icos) Agonist Gsk3359609 (Gsk609) With Platinum+5-Fu Chemotherapy (5-Fu/Plat), With Or Without Pembrolizumab (Pe), For The Treatment Of Advanced Solid Tumors.
JOURNAL OF CLINICAL ONCOLOGY（2020）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要